Different Units By MoH Code
Revision Date : 11/01/2013
NovoSeven RT 100KIU MoH 5539 :
Form
Powder and solvent for solution for injection
Packaging
Pre-filled Syringes + Vials (Type I glass)
Package Size
1+1
Strength
2mg (100KIU)
Public Price
1689135 L.L.
Stratum
E2
NSSF
✔
Quarantine
✘
Reg. Number
218018/09
Submission date
01/01/2009
Registration Year
2009
abcdefhiklmnopqrstuvwxyz Loading chart. Please wait. abcdefhiklmnopqrstuvwxyz Date Price 0 26M 52M 78M 104M 130M 2009-09-30 2009-10-24 2010-03-27 2010-04-20 2010-05-15 2010-05-31 2010-07-31 2010-10-14 2010-10-29 2010-12-01 2011-01-04 2011-06-14 2011-10-22 2012-04-05 2012-07-27 2012-12-21 2013-01-07 2013-04-02 2013-10-11 2014-03-26 2014-06-19 2014-10-14 2015-01-13 2015-04-07 2015-07-30 2015-11-30 2016-01-11 2016-04-11 2016-12-09 2017-01-11 2017-06-16 2017-11-09 2018-01-22 2018-02-19 2018-05-17 2018-08-20 2018-12-21 2019-02-01 2019-08-28 2019-12-17 2020-01-09 2020-03-02 2020-07-02 2020-08-03 2020-12-03 2021-09-03 2021-11-03 2021-12-07 2022-03-01 2022-05-11 2022-07-14 2022-10-04 2022-11-01 2022-12-12 2023-04-03 2023-09-05 2023-12-05 2024-01-10 2024-02-05 2024-06-13
●
Country:
Italy
●
Package Size:
1+1x2.1ml
●
Public Price:
2158.24 EUR
( 209,081,658.24 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
2158,24 EUR
( 209,058,408.00 LBP )
●
Exfactory Price:
1307.7 EUR
●
Pricing Date:
17/12/2019
●
Type:
Medicine Authorised
●
Country:
Qatar
●
Package Size:
1
●
Public Price:
7927 QAR
( 194,671,266.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
7927 QAR
( 194,671,266.00 LBP )
●
Pharmacy Price:
6510.94417298 QAR
( 159895767.00004 LBP )
●
Pricing Date:
28/01/2021
●
Type:
Medicine Authorised
●
Country:
Oman
●
Package Size:
1+1
●
Public Price:
834.57 OMR
( 192,563,674.38 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
834,57 OMR
( 192,432,156.00 LBP )
●
Pricing Date:
19/02/2021
●
Type:
Medicine Authorised
●
Country:
Kuweit
●
Package Size:
1+1
●
Public Price:
638.4 KWD
( 187,422,110.40 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
638,4 KWD
( 187,304,678.00 LBP )
●
Pharmacy Price:
539.34 KWD
( 158339976.54 LBP )
●
Pricing Date:
07/02/2021
●
Type:
Medicine Authorised
●
Country:
Switzerland
●
Package Size:
1+1
●
Public Price:
1774.15 CHF
( 183,482,593.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1774,15 CHF
( 183,467,080.00 LBP )
●
Exfactory Price:
1690.88 CHF
●
Pricing Date:
04/04/2021
●
Type:
Medicine Authorised
●
Country:
Abu Dhabi
●
Package Size:
1+1x2.1ml
●
Public Price:
7406.5 AED
( 178,948,446.50 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
●
Pharmacy Price:
6309.52 AED
( 152444312.72 LBP )
●
Pricing Date:
27/01/2021
●
Type:
Medicine Authorised
●
Country:
UAE
●
Package Size:
1 Vial (Powder) + 1 Solvent Vial (2.1ml)
●
Public Price:
7406.5 AED
( 178,948,446.50 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
●
Pharmacy Price:
6309.52 AED
( 152444312.72 LBP )
●
Pricing Date:
21/08/2019
●
Type:
Medicine Authorised
●
Country:
Bahrain
●
Package Size:
1+1
●
Public Price:
704.5 BHD
( 167,483,603.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
704,5 BHD
( 167,364,736.00 LBP )
●
Reference:
nhra
●
Pricing Date:
09/02/2021
●
Type:
Medicine Authorised
●
Country:
Finland
●
Package Size:
1+1x2ml
●
Public Price:
1579.45 EUR
( 153,010,798.20 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1579,45 EUR
( 152,967,204.00 LBP )
●
Reference:
Kela
●
Pricing Date:
22/04/2021
●
Type:
Medicine Authorised
●
Country:
Iceland
●
Package Size:
1+1
●
Public Price:
216970 ISK
( 139,945,650.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
216970 ISK
( 139,945,650.00 LBP )
●
Pharmacy Price:
169345 ISK
( 109227525 LBP )
●
Reference:
Icelandic Medicines Agency
●
Pricing Date:
01/04/2020
●
Type:
Medicine Authorised
●
Country:
Denmark
●
Package Size:
1+1
●
Public Price:
10629.4 DKK
( 137,927,094.40 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
10629,4 DKK
( 137,921,904.00 LBP )
●
Pharmacy Price:
7897.84 DKK
( 102482371.84 LBP )
●
Reference:
Danish Medicine Agency
●
Pricing Date:
19/05/2021
●
Type:
Medicine Authorised
●
Country:
Czech Republic
●
Package Size:
1+1x2ml
●
Public Price:
34221.93 CZK
( 130,693,550.67 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
34221,93 CZK
( 130,689,999.00 LBP )
●
Reference:
SUKL
●
Pricing Date:
28/02/2020
●
Type:
Medicine Authorised
●
Country:
KSA
●
Package Size:
2mg
●
Public Price:
5290.4 SAR
( 125,065,056.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
5290,4 SAR
( 125,055,600.00 LBP )
●
Reference:
sfda
●
Pricing Date:
16/01/2021
●
Type:
Medicine Authorised
●
Country:
Cyprus
●
Package Size:
1 x 2ml
●
Public Price:
1263.97 EUR
( 122,448,357.72 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1263,97 EUR
( 122,354,388.00 LBP )
●
Reference:
Cyprus Minister of Health
●
Pricing Date:
24/03/2021
●
Type:
Medicine Authorised
●
Country:
Greece
●
Package Size:
1+1
●
Public Price:
1260.19 EUR
( 122,082,166.44 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1260,19 EUR
( 122,063,760.00 LBP )
●
Exfactory Price:
1115.49 EUR
●
Pharmacy Price:
1132.25 EUR
( 109687851 LBP )
●
Reference:
National Organization for Medicines
●
Pricing Date:
25/02/2021
●
Type:
Medicine Authorised
●
Country:
UK
●
Package Size:
1+1
●
Public Price:
1050.4 GBP
( 119,376,909.60 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1050,4 GBP
( 119,331,450.00 LBP )
●
Reference:
DMD
●
Pricing Date:
08/03/2021
●
Type:
Medicine Authorised
●
Country:
Spain
●
Package Size:
1 vial + 1xdisolvente
●
Public Price:
1220.48 EUR
( 118,235,220.48 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1220,48 EUR
( 118,188,720.00 LBP )
●
Reference:
Agencia Española de Medicamentos y Productos Sanitarios
●
Pricing Date:
06/05/2021
●
Type:
Medicine Non Marketed
●
Country:
France
●
Package Size:
1+1
●
Public Price:
1216 EUR
( 117,801,216.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1216 EUR
( 117,801,216.00 LBP )
●
Reference:
ansm
●
Pricing Date:
15/05/2021
●
Type:
Medicine Authorised
●
Country:
Belgium
●
Package Size:
1+1x2.1ml
●
Public Price:
1065 EUR
( 103,172,940.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1065 EUR
( 103,172,940.00 LBP )
●
Reference:
cbip
●
Pricing Date:
02/12/2020
●
Type:
Medicine Authorised
●
Country:
Norway
●
Package Size:
1
●
Public Price:
12060.5 NOK
( 97,738,292.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
12060,5 NOK
( 97,734,240.00 LBP )
●
Pharmacy Price:
9430.82 NOK
( 76427365.28 LBP )
●
Reference:
Norwegian Medicine Agency
●
Pricing Date:
01/04/2020
●
Type:
Medicine Authorised
●
Country:
Sweden
●
Package Size:
1+1
●
Public Price:
11420.85 SEK
( 96,026,506.80 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
11420,85 SEK
( 96,019,360.00 LBP )
●
Pharmacy Price:
11151.57 SEK
( 93762400.56 LBP )
●
Pricing Date:
23/04/2020
●
Type:
Medicine Authorised
●
Country:
Turkey
●
Package Size:
1
●
Public Price:
5801.16 TRY
( 15,547,108.80 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
5801,16 TRY
( 15,546,680.00 LBP )
●
Pricing Date:
28/10/2020
●
Type:
Medicine Authorised
●
Country:
Lebanon
●
Form:
Powder and solvent for solution for injection
●
Package Size:
1+1
●
Public Price:
1689135 LBP
( 1,689,135.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1689135 LBP
( 1,689,135.00 LBP )
●
Pricing Date:
13/06/2024
●
Country:
The Netherlands
●
Package Size:
1
●
Reference:
Zorginstituut Nederland
●
Pricing Date:
15/06/2019
●
Type:
Medicine Non Marketed
●
Country:
New Zealand
●
Package Size:
1 inj
●
Exfactory Price:
2356.6 NZD
●
Reference:
New Zealand Pharmaceutical Management Agency
●
Pricing Date:
01/04/2020
●
Type:
Medicine Authorised
●
Country:
Portugal
●
Package Size:
1+1
●
Reference:
Autoridade Nacional do Medicamento e Produtos de Saúde
●
Pricing Date:
22/04/2019
abcdefhiklmnopqrstuvwxyz Loading chart. Please wait. abcdefhiklmnopqrstuvwxyz Country Price/Unit 0 60M 120M 180M 240M 300M Italy Qatar Oman Kuweit Switzerland Abu Dhabi UAE Bahrain Finland Iceland Denmark Czech Republic KSA Cyprus Greece UK Spain France Belgium Norway Sweden Turkey Lebanon
Acquired haemophilia :
●
Cost/Unit:
2158,24 EUR
( 209,058,408.00 LBP )
● Cost/Day:
6474,72 EUR
( 627,175,224.00 LBP )
●
Cost/Month:
6474,72 EUR
( 627,175,224.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
2158,24 EUR
( 209,058,408.00 LBP )
● Cost/Day:
6474,72 EUR
( 627,175,224.00 LBP )
●
Cost/Month:
6474,72 EUR
( 627,175,224.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
2158,24 EUR
( 209,058,408.00 LBP )
● Cost/Day:
6474,72 EUR
( 627,175,224.00 LBP )
●
Cost/Month:
6474,72 EUR
( 627,175,224.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
2158,24 EUR
( 209,058,408.00 LBP )
● Cost/Day:
6474,72 EUR
( 627,175,224.00 LBP )
●
Cost/Month:
6474,72 EUR
( 627,175,224.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
2158,24 EUR
( 209,058,408.00 LBP )
● Cost/Day:
6474,72 EUR
( 627,175,224.00 LBP )
●
Cost/Month:
6474,72 EUR
( 627,175,224.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
7927 QAR
( 194,671,266.00 LBP )
● Cost/Day:
23781 QAR
( 584,013,798.00 LBP )
●
Cost/Month:
23781 QAR
( 584,013,798.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
7927 QAR
( 194,671,266.00 LBP )
● Cost/Day:
23781 QAR
( 584,013,798.00 LBP )
●
Cost/Month:
23781 QAR
( 584,013,798.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
7927 QAR
( 194,671,266.00 LBP )
● Cost/Day:
23781 QAR
( 584,013,798.00 LBP )
●
Cost/Month:
23781 QAR
( 584,013,798.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
7927 QAR
( 194,671,266.00 LBP )
● Cost/Day:
23781 QAR
( 584,013,798.00 LBP )
●
Cost/Month:
23781 QAR
( 584,013,798.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
7927 QAR
( 194,671,266.00 LBP )
● Cost/Day:
23781 QAR
( 584,013,798.00 LBP )
●
Cost/Month:
23781 QAR
( 584,013,798.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
834,57 OMR
( 192,432,156.00 LBP )
● Cost/Day:
2503,71 OMR
( 577,527,202.00 LBP )
●
Cost/Month:
2503,71 OMR
( 577,527,202.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
834,57 OMR
( 192,432,156.00 LBP )
● Cost/Day:
2503,71 OMR
( 577,527,202.00 LBP )
●
Cost/Month:
2503,71 OMR
( 577,527,202.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
834,57 OMR
( 192,432,156.00 LBP )
● Cost/Day:
2503,71 OMR
( 577,527,202.00 LBP )
●
Cost/Month:
2503,71 OMR
( 577,527,202.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
834,57 OMR
( 192,432,156.00 LBP )
● Cost/Day:
2503,71 OMR
( 577,527,202.00 LBP )
●
Cost/Month:
2503,71 OMR
( 577,527,202.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
834,57 OMR
( 192,432,156.00 LBP )
● Cost/Day:
2503,71 OMR
( 577,527,202.00 LBP )
●
Cost/Month:
2503,71 OMR
( 577,527,202.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
638,4 KWD
( 187,304,678.00 LBP )
● Cost/Day:
1915,2 KWD
( 562,207,615.00 LBP )
●
Cost/Month:
1915,2 KWD
( 562,207,615.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
638,4 KWD
( 187,304,678.00 LBP )
● Cost/Day:
1915,2 KWD
( 562,207,615.00 LBP )
●
Cost/Month:
1915,2 KWD
( 562,207,615.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
638,4 KWD
( 187,304,678.00 LBP )
● Cost/Day:
1915,2 KWD
( 562,207,615.00 LBP )
●
Cost/Month:
1915,2 KWD
( 562,207,615.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
638,4 KWD
( 187,304,678.00 LBP )
● Cost/Day:
1915,2 KWD
( 562,207,615.00 LBP )
●
Cost/Month:
1915,2 KWD
( 562,207,615.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
638,4 KWD
( 187,304,678.00 LBP )
● Cost/Day:
1915,2 KWD
( 562,207,615.00 LBP )
●
Cost/Month:
1915,2 KWD
( 562,207,615.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1774,15 CHF
( 183,467,080.00 LBP )
● Cost/Day:
5322,45 CHF
( 550,401,240.00 LBP )
●
Cost/Month:
5322,45 CHF
( 550,401,240.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1774,15 CHF
( 183,467,080.00 LBP )
● Cost/Day:
5322,45 CHF
( 550,401,240.00 LBP )
●
Cost/Month:
5322,45 CHF
( 550,401,240.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1774,15 CHF
( 183,467,080.00 LBP )
● Cost/Day:
5322,45 CHF
( 550,401,240.00 LBP )
●
Cost/Month:
5322,45 CHF
( 550,401,240.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1774,15 CHF
( 183,467,080.00 LBP )
● Cost/Day:
5322,45 CHF
( 550,401,240.00 LBP )
●
Cost/Month:
5322,45 CHF
( 550,401,240.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1774,15 CHF
( 183,467,080.00 LBP )
● Cost/Day:
5322,45 CHF
( 550,401,240.00 LBP )
●
Cost/Month:
5322,45 CHF
( 550,401,240.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
7406,5 AED
( 178,936,366.00 LBP )
● Cost/Day:
22219,5 AED
( 536,833,259.00 LBP )
●
Cost/Month:
22219,5 AED
( 536,833,259.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
704,5 BHD
( 167,364,736.00 LBP )
● Cost/Day:
2113,5 BHD
( 502,331,942.00 LBP )
●
Cost/Month:
2113,5 BHD
( 502,331,942.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
704,5 BHD
( 167,364,736.00 LBP )
● Cost/Day:
2113,5 BHD
( 502,331,942.00 LBP )
●
Cost/Month:
2113,5 BHD
( 502,331,942.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
704,5 BHD
( 167,364,736.00 LBP )
● Cost/Day:
2113,5 BHD
( 502,331,942.00 LBP )
●
Cost/Month:
2113,5 BHD
( 502,331,942.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
704,5 BHD
( 167,364,736.00 LBP )
● Cost/Day:
2113,5 BHD
( 502,331,942.00 LBP )
●
Cost/Month:
2113,5 BHD
( 502,331,942.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
704,5 BHD
( 167,364,736.00 LBP )
● Cost/Day:
2113,5 BHD
( 502,331,942.00 LBP )
●
Cost/Month:
2113,5 BHD
( 502,331,942.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1579,45 EUR
( 152,967,204.00 LBP )
● Cost/Day:
4738,35 EUR
( 458,998,488.00 LBP )
●
Cost/Month:
4738,35 EUR
( 458,998,488.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1579,45 EUR
( 152,967,204.00 LBP )
● Cost/Day:
4738,35 EUR
( 458,998,488.00 LBP )
●
Cost/Month:
4738,35 EUR
( 458,998,488.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1579,45 EUR
( 152,967,204.00 LBP )
● Cost/Day:
4738,35 EUR
( 458,998,488.00 LBP )
●
Cost/Month:
4738,35 EUR
( 458,998,488.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1579,45 EUR
( 152,967,204.00 LBP )
● Cost/Day:
4738,35 EUR
( 458,998,488.00 LBP )
●
Cost/Month:
4738,35 EUR
( 458,998,488.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1579,45 EUR
( 152,967,204.00 LBP )
● Cost/Day:
4738,35 EUR
( 458,998,488.00 LBP )
●
Cost/Month:
4738,35 EUR
( 458,998,488.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
216970 ISK
( 139,945,650.00 LBP )
● Cost/Day:
650910 ISK
( 419,836,950.00 LBP )
●
Cost/Month:
650910 ISK
( 419,836,950.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
216970 ISK
( 139,945,650.00 LBP )
● Cost/Day:
650910 ISK
( 419,836,950.00 LBP )
●
Cost/Month:
650910 ISK
( 419,836,950.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
216970 ISK
( 139,945,650.00 LBP )
● Cost/Day:
650910 ISK
( 419,836,950.00 LBP )
●
Cost/Month:
650910 ISK
( 419,836,950.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
216970 ISK
( 139,945,650.00 LBP )
● Cost/Day:
650910 ISK
( 419,836,950.00 LBP )
●
Cost/Month:
650910 ISK
( 419,836,950.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
216970 ISK
( 139,945,650.00 LBP )
● Cost/Day:
650910 ISK
( 419,836,950.00 LBP )
●
Cost/Month:
650910 ISK
( 419,836,950.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
10629,4 DKK
( 137,921,904.00 LBP )
● Cost/Day:
31888,2 DKK
( 413,778,688.00 LBP )
●
Cost/Month:
31888,2 DKK
( 413,778,688.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
10629,4 DKK
( 137,921,904.00 LBP )
● Cost/Day:
31888,2 DKK
( 413,778,688.00 LBP )
●
Cost/Month:
31888,2 DKK
( 413,778,688.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
10629,4 DKK
( 137,921,904.00 LBP )
● Cost/Day:
31888,2 DKK
( 413,778,688.00 LBP )
●
Cost/Month:
31888,2 DKK
( 413,778,688.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
10629,4 DKK
( 137,921,904.00 LBP )
● Cost/Day:
31888,2 DKK
( 413,778,688.00 LBP )
●
Cost/Month:
31888,2 DKK
( 413,778,688.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
10629,4 DKK
( 137,921,904.00 LBP )
● Cost/Day:
31888,2 DKK
( 413,778,688.00 LBP )
●
Cost/Month:
31888,2 DKK
( 413,778,688.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
34221,93 CZK
( 130,689,999.00 LBP )
● Cost/Day:
102665,79 CZK
( 392,077,635.00 LBP )
●
Cost/Month:
102665,79 CZK
( 392,077,635.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
34221,93 CZK
( 130,689,999.00 LBP )
● Cost/Day:
102665,79 CZK
( 392,077,635.00 LBP )
●
Cost/Month:
102665,79 CZK
( 392,077,635.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
34221,93 CZK
( 130,689,999.00 LBP )
● Cost/Day:
102665,79 CZK
( 392,077,635.00 LBP )
●
Cost/Month:
102665,79 CZK
( 392,077,635.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
34221,93 CZK
( 130,689,999.00 LBP )
● Cost/Day:
102665,79 CZK
( 392,077,635.00 LBP )
●
Cost/Month:
102665,79 CZK
( 392,077,635.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
34221,93 CZK
( 130,689,999.00 LBP )
● Cost/Day:
102665,79 CZK
( 392,077,635.00 LBP )
●
Cost/Month:
102665,79 CZK
( 392,077,635.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
5290,4 SAR
( 125,055,600.00 LBP )
● Cost/Day:
15871,2 SAR
( 375,190,440.00 LBP )
●
Cost/Month:
15871,2 SAR
( 375,190,440.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
5290,4 SAR
( 125,055,600.00 LBP )
● Cost/Day:
15871,2 SAR
( 375,190,440.00 LBP )
●
Cost/Month:
15871,2 SAR
( 375,190,440.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
5290,4 SAR
( 125,055,600.00 LBP )
● Cost/Day:
15871,2 SAR
( 375,190,440.00 LBP )
●
Cost/Month:
15871,2 SAR
( 375,190,440.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
5290,4 SAR
( 125,055,600.00 LBP )
● Cost/Day:
15871,2 SAR
( 375,190,440.00 LBP )
●
Cost/Month:
15871,2 SAR
( 375,190,440.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
5290,4 SAR
( 125,055,600.00 LBP )
● Cost/Day:
15871,2 SAR
( 375,190,440.00 LBP )
●
Cost/Month:
15871,2 SAR
( 375,190,440.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1263,97 EUR
( 122,354,388.00 LBP )
● Cost/Day:
3791,91 EUR
( 367,256,916.00 LBP )
●
Cost/Month:
3791,91 EUR
( 367,256,916.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1263,97 EUR
( 122,354,388.00 LBP )
● Cost/Day:
3791,91 EUR
( 367,256,916.00 LBP )
●
Cost/Month:
3791,91 EUR
( 367,256,916.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1263,97 EUR
( 122,354,388.00 LBP )
● Cost/Day:
3791,91 EUR
( 367,256,916.00 LBP )
●
Cost/Month:
3791,91 EUR
( 367,256,916.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1263,97 EUR
( 122,354,388.00 LBP )
● Cost/Day:
3791,91 EUR
( 367,256,916.00 LBP )
●
Cost/Month:
3791,91 EUR
( 367,256,916.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1263,97 EUR
( 122,354,388.00 LBP )
● Cost/Day:
3791,91 EUR
( 367,256,916.00 LBP )
●
Cost/Month:
3791,91 EUR
( 367,256,916.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1260,19 EUR
( 122,063,760.00 LBP )
● Cost/Day:
3780,57 EUR
( 366,191,280.00 LBP )
●
Cost/Month:
3780,57 EUR
( 366,191,280.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1260,19 EUR
( 122,063,760.00 LBP )
● Cost/Day:
3780,57 EUR
( 366,191,280.00 LBP )
●
Cost/Month:
3780,57 EUR
( 366,191,280.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1260,19 EUR
( 122,063,760.00 LBP )
● Cost/Day:
3780,57 EUR
( 366,191,280.00 LBP )
●
Cost/Month:
3780,57 EUR
( 366,191,280.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1260,19 EUR
( 122,063,760.00 LBP )
● Cost/Day:
3780,57 EUR
( 366,191,280.00 LBP )
●
Cost/Month:
3780,57 EUR
( 366,191,280.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1260,19 EUR
( 122,063,760.00 LBP )
● Cost/Day:
3780,57 EUR
( 366,191,280.00 LBP )
●
Cost/Month:
3780,57 EUR
( 366,191,280.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1050,4 GBP
( 119,331,450.00 LBP )
● Cost/Day:
3151,2 GBP
( 358,107,999.00 LBP )
●
Cost/Month:
3151,2 GBP
( 358,107,999.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1050,4 GBP
( 119,331,450.00 LBP )
● Cost/Day:
3151,2 GBP
( 358,107,999.00 LBP )
●
Cost/Month:
3151,2 GBP
( 358,107,999.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1050,4 GBP
( 119,331,450.00 LBP )
● Cost/Day:
3151,2 GBP
( 358,107,999.00 LBP )
●
Cost/Month:
3151,2 GBP
( 358,107,999.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1050,4 GBP
( 119,331,450.00 LBP )
● Cost/Day:
3151,2 GBP
( 358,107,999.00 LBP )
●
Cost/Month:
3151,2 GBP
( 358,107,999.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1050,4 GBP
( 119,331,450.00 LBP )
● Cost/Day:
3151,2 GBP
( 358,107,999.00 LBP )
●
Cost/Month:
3151,2 GBP
( 358,107,999.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1220,48 EUR
( 118,188,720.00 LBP )
● Cost/Day:
3661,44 EUR
( 354,663,036.00 LBP )
●
Cost/Month:
3661,44 EUR
( 354,663,036.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1220,48 EUR
( 118,188,720.00 LBP )
● Cost/Day:
3661,44 EUR
( 354,663,036.00 LBP )
●
Cost/Month:
3661,44 EUR
( 354,663,036.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1220,48 EUR
( 118,188,720.00 LBP )
● Cost/Day:
3661,44 EUR
( 354,663,036.00 LBP )
●
Cost/Month:
3661,44 EUR
( 354,663,036.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1220,48 EUR
( 118,188,720.00 LBP )
● Cost/Day:
3661,44 EUR
( 354,663,036.00 LBP )
●
Cost/Month:
3661,44 EUR
( 354,663,036.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1220,48 EUR
( 118,188,720.00 LBP )
● Cost/Day:
3661,44 EUR
( 354,663,036.00 LBP )
●
Cost/Month:
3661,44 EUR
( 354,663,036.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1216 EUR
( 117,801,216.00 LBP )
● Cost/Day:
3648 EUR
( 353,403,648.00 LBP )
●
Cost/Month:
3648 EUR
( 353,403,648.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1216 EUR
( 117,801,216.00 LBP )
● Cost/Day:
3648 EUR
( 353,403,648.00 LBP )
●
Cost/Month:
3648 EUR
( 353,403,648.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1216 EUR
( 117,801,216.00 LBP )
● Cost/Day:
3648 EUR
( 353,403,648.00 LBP )
●
Cost/Month:
3648 EUR
( 353,403,648.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1216 EUR
( 117,801,216.00 LBP )
● Cost/Day:
3648 EUR
( 353,403,648.00 LBP )
●
Cost/Month:
3648 EUR
( 353,403,648.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1216 EUR
( 117,801,216.00 LBP )
● Cost/Day:
3648 EUR
( 353,403,648.00 LBP )
●
Cost/Month:
3648 EUR
( 353,403,648.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1065 EUR
( 103,172,940.00 LBP )
● Cost/Day:
3195 EUR
( 309,518,820.00 LBP )
●
Cost/Month:
3195 EUR
( 309,518,820.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1065 EUR
( 103,172,940.00 LBP )
● Cost/Day:
3195 EUR
( 309,518,820.00 LBP )
●
Cost/Month:
3195 EUR
( 309,518,820.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1065 EUR
( 103,172,940.00 LBP )
● Cost/Day:
3195 EUR
( 309,518,820.00 LBP )
●
Cost/Month:
3195 EUR
( 309,518,820.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1065 EUR
( 103,172,940.00 LBP )
● Cost/Day:
3195 EUR
( 309,518,820.00 LBP )
●
Cost/Month:
3195 EUR
( 309,518,820.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1065 EUR
( 103,172,940.00 LBP )
● Cost/Day:
3195 EUR
( 309,518,820.00 LBP )
●
Cost/Month:
3195 EUR
( 309,518,820.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
12060,5 NOK
( 97,734,240.00 LBP )
● Cost/Day:
36181,5 NOK
( 293,210,824.00 LBP )
●
Cost/Month:
36181,5 NOK
( 293,210,824.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
12060,5 NOK
( 97,734,240.00 LBP )
● Cost/Day:
36181,5 NOK
( 293,210,824.00 LBP )
●
Cost/Month:
36181,5 NOK
( 293,210,824.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
12060,5 NOK
( 97,734,240.00 LBP )
● Cost/Day:
36181,5 NOK
( 293,210,824.00 LBP )
●
Cost/Month:
36181,5 NOK
( 293,210,824.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
12060,5 NOK
( 97,734,240.00 LBP )
● Cost/Day:
36181,5 NOK
( 293,210,824.00 LBP )
●
Cost/Month:
36181,5 NOK
( 293,210,824.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
12060,5 NOK
( 97,734,240.00 LBP )
● Cost/Day:
36181,5 NOK
( 293,210,824.00 LBP )
●
Cost/Month:
36181,5 NOK
( 293,210,824.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
11420,85 SEK
( 96,019,360.00 LBP )
● Cost/Day:
34262,55 SEK
( 288,074,896.00 LBP )
●
Cost/Month:
34262,55 SEK
( 288,074,896.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
11420,85 SEK
( 96,019,360.00 LBP )
● Cost/Day:
34262,55 SEK
( 288,074,896.00 LBP )
●
Cost/Month:
34262,55 SEK
( 288,074,896.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
11420,85 SEK
( 96,019,360.00 LBP )
● Cost/Day:
34262,55 SEK
( 288,074,896.00 LBP )
●
Cost/Month:
34262,55 SEK
( 288,074,896.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
11420,85 SEK
( 96,019,360.00 LBP )
● Cost/Day:
34262,55 SEK
( 288,074,896.00 LBP )
●
Cost/Month:
34262,55 SEK
( 288,074,896.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
11420,85 SEK
( 96,019,360.00 LBP )
● Cost/Day:
34262,55 SEK
( 288,074,896.00 LBP )
●
Cost/Month:
34262,55 SEK
( 288,074,896.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
5801,16 TRY
( 15,546,680.00 LBP )
● Cost/Day:
17403,48 TRY
( 46,640,040.00 LBP )
●
Cost/Month:
17403,48 TRY
( 46,640,040.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
5801,16 TRY
( 15,546,680.00 LBP )
● Cost/Day:
17403,48 TRY
( 46,640,040.00 LBP )
●
Cost/Month:
17403,48 TRY
( 46,640,040.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
5801,16 TRY
( 15,546,680.00 LBP )
● Cost/Day:
17403,48 TRY
( 46,640,040.00 LBP )
●
Cost/Month:
17403,48 TRY
( 46,640,040.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
5801,16 TRY
( 15,546,680.00 LBP )
● Cost/Day:
17403,48 TRY
( 46,640,040.00 LBP )
●
Cost/Month:
17403,48 TRY
( 46,640,040.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
5801,16 TRY
( 15,546,680.00 LBP )
● Cost/Day:
17403,48 TRY
( 46,640,040.00 LBP )
●
Cost/Month:
17403,48 TRY
( 46,640,040.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1689135 LBP
( 1,689,135.00 LBP )
● Cost/Day:
5067405 LBP
( 5,067,405.00 LBP )
●
Cost/Month:
5067405 LBP
( 5,067,405.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1689135 LBP
( 1,689,135.00 LBP )
● Cost/Day:
5067405 LBP
( 5,067,405.00 LBP )
●
Cost/Month:
5067405 LBP
( 5,067,405.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1689135 LBP
( 1,689,135.00 LBP )
● Cost/Day:
5067405 LBP
( 5,067,405.00 LBP )
●
Cost/Month:
5067405 LBP
( 5,067,405.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1689135 LBP
( 1,689,135.00 LBP )
● Cost/Day:
5067405 LBP
( 5,067,405.00 LBP )
●
Cost/Month:
5067405 LBP
( 5,067,405.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1689135 LBP
( 1,689,135.00 LBP )
● Cost/Day:
5067405 LBP
( 5,067,405.00 LBP )
●
Cost/Month:
5067405 LBP
( 5,067,405.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info
You have to register to view this info